5/1
11:25 am
fold
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know [Yahoo! Finance]
Low
Report
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know [Yahoo! Finance]
5/1
07:00 am
fold
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
Medium
Report
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
4/19
10:54 am
fold
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? [Yahoo! Finance]
Low
Report
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? [Yahoo! Finance]
3/29
12:57 pm
fold
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? [Yahoo! Finance]
3/20
07:12 am
fold
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Low
Report
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
3/20
07:00 am
fold
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
Low
Report
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
3/18
02:51 pm
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Low
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $19.00. They now have an "overweight" rating on the stock.
3/7
12:13 am
fold
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) [Yahoo! Finance]
Low
Report
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) [Yahoo! Finance]
2/28/2024
07:00 am
fold
amicus therapeutics, inc.
BEAT
Report
-10.1%
amicus therapeutics, inc.
11/8/2023
07:00 am
fold
amicus therapeutics, inc.
BEAT
Report
0.4%
amicus therapeutics, inc.
8/8/2023
07:00 am
fold
amicus therapeutics, inc.
MISS
Report
4.2%
amicus therapeutics, inc.
5/10/2023
07:00 am
fold
amicus therapeutics, inc.
MISS
Report
-5.0%
amicus therapeutics, inc.
5/3
05:21 pm
fold
Form 4 AMICUS THERAPEUTICS, For: May 01 Filed by: Campbell Bradley L
Low
Report
Form 4 AMICUS THERAPEUTICS, For: May 01 Filed by: Campbell Bradley L
5/1
04:26 pm
fold
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
Low
Report
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
4/24
05:11 pm
fold
Form ARS AMICUS THERAPEUTICS, For: Dec 31
Medium
Report
Form ARS AMICUS THERAPEUTICS, For: Dec 31
4/24
04:37 pm
fold
Form DEF 14A AMICUS THERAPEUTICS, For: Jun 06
Medium
Report
Form DEF 14A AMICUS THERAPEUTICS, For: Jun 06
4/24
04:35 pm
fold
Form DEFA14A AMICUS THERAPEUTICS,
Medium
Report
Form DEFA14A AMICUS THERAPEUTICS,
4/16
05:42 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Apr 15 Filed by: Prout Samantha
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Apr 15 Filed by: Prout Samantha
4/15
04:28 pm
fold
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
Low
Report
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
4/3
06:14 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Apr 01 Filed by: Campbell Bradley L
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Apr 01 Filed by: Campbell Bradley L
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
4/2
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
8.5%
2/4
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00.
7.0%
3/9
Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L
6.9%
2/4
Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F
6.5%
6/17
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
5.8%
1/14
Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay
5.4%
10/3
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News]
4.8%
3/24
Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F
4.4%
7/17
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
4.4%
4/24
Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020
4.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register